查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1496771

制酸劑市場：依藥物類別、劑型、適應症、通路分類 - 全球預測 2024-2030

Antacids Market by Drug Class (Acid Neutralizers, H2 Antagonist, Promotility Agents), Formulation (Liquid, Powder, Tablet), Indication, Distribution Channel - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年制酸劑市場規模為68.5億美元，預計2024年將達72.4億美元，2030年將達到101.8億美元，複合年成長率為5.81%。

制酸劑是一種用於中和胃酸並緩解胃酸過多相關症狀的藥物。這包括胃灼熱、消化不良和胃部不適等症狀，這些症狀可以透過增加胃部的 pH 平衡來緩解。制酸劑有多種形式出售，包括錠劑、液體和粉末，用於緩解與胃食道逆流 (GERD)、胃灼熱和消化性潰瘍相關的症狀。全球胃食道逆流症 (GERD)、胃灼熱和其他胃部疾病的盛行率不斷增加，這增加了對制酸劑的需求。現代飲食和生活方式導致酸性消化不良和相關疾病的增加，進一步推動了對制酸劑的需求。旨在提高產品功效和減少副作用的持續研究和開發對市場成長有正面影響。然而，有關制酸劑核准和銷售的嚴格規定可能會延遲產品上市並阻礙市場成長。替代療法和酸相關疾病治療的可用性對市場成長構成了重大挑戰。此外，對天然和有機成分的研究正在取得進展，可以有效緩解缺氧及相關症狀，為市場成長創造機會。提高抗酸產品功效和作用持續時間的藥物傳輸技術創新正在進行中，為市場創造了成長潛力。

主要市場統計
基準年[2023] 68.5億美元
預測年份 [2024] 72.4億美元
預測年份 [2030] 101.8億美元
複合年成長率（%） 5.81%

區域洞察

美洲地區的制酸劑市場是由胃食道逆流（GERD）和壓力性胃炎以及其他胃腸道疾病的高盛行率所推動的。在美國和加拿大等主要國家，消費者的偏好正趨向速效、調味和咀嚼產品。 EMEA（歐洲、中東和非洲）地區呈現多樣化的格局，因為歐盟國家由於嚴格的監管而優先考慮基於醫學證明的處方箋的治療。歐洲、中東和非洲市場的特點是全球製藥品牌眾多，人們對具有其他健康益處（例如益生菌）的制酸劑越來越感興趣。在文明病和自我治療日益成長的推動下，中東和非洲的制酸劑市場正在擴大。此外，在亞太地區，中國和印度不斷壯大的中階以及不斷成長的醫療保健支出正在推動制酸劑的廣泛採用。由於日本人口老化以及對預防性醫療保健的日益重視，制酸劑的使用在亞太地區正在擴大。印度國內制酸劑市場的推動因素包括生活方式的改變、速食消費的增加以及人們對非處方藥 (OTC) 認知的提高。

FPNV定位矩陣

FPNV 定位矩陣對於評估制酸劑市場供應商的市場定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對制酸劑市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該行業競爭性質的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在制酸劑市場中的地位進行全面評估，使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 患有胃食道逆流的人數正在增加
      • 全球政府對國內藥品製造的措施與投資
    • 抑制因素
      • 針對酸度相關問題的家庭療法和其他替代療法的可用性
    • 機會
      • 開發具有更直接和持久效果的制酸劑
      • 線上藥局可以輕鬆可得性制酸劑，並且成藥的監管靈活性
    • 任務
      • 與制酸劑相關的藥品召回和污染問題
  • 市場區隔分析
    • 藥物類別：增加對酸中和劑的偏好以提高治療效果
    • 適應症：在胃食道逆流症的治療中越來越需要制酸劑，以降低胃酸對食道內壁的損害。
    • 配方：人們越來越喜歡液體制酸劑，因為它們已經溶解並且可以更快地緩解症狀。
    • 通路：零售藥局制酸劑的供應量增加，無需處方箋即可輕鬆取得制酸劑
  • 市場趨勢分析
    • 在美洲，胃食道逆流症的盛行率正在增加，增加了對制酸劑的需求。
    • 旨在提高亞太地區改善消化器官系統健康意識的政府宣傳活動
    • 歐洲、中東和非洲地區擁有成熟的製藥業和政府對國內藥品生產的支持。
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析

第6章依藥物類別分類的制酸劑市場

  • 酸中和劑
  • H2拮抗劑
  • 促銷代理
  • 質子幫浦抑制劑

第7章制酸劑市場

  • 液體
  • 粉末
  • 藥片

第8章按適應症分類的制酸劑市場

  • 胃食道逆流症
  • 消化不良/消化不良
  • 消化性潰瘍

第9章制酸劑市場：按通路

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第10章美洲制酸劑市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太制酸劑市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲制酸劑市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • TUMS 與 DraftKings 和 Desus Nice 合作推出TUMS Prop Bites，讓大型遊戲迷第一次可以盡情享受美食。
    • Dexel Pharma 收購八個 OTC 品牌以強化消費者保健產品組合
    • Camber Pharmaceuticals 推出非專利Wellbutrin SR
    • 利潔時在泰米爾納德邦推出 Gaviscon Double Action，幫助患有胃酸過多和胃灼熱的人們
    • Wonderberry 擴展到 1,800 多家 Target 商店，以便更輕鬆地接觸更廣泛的客戶群
    • 剪切機-Smith 推出法莫替丁口服懸浮液
    • ZydusEsomeprazole鎂產品獲得美國FDA 最終核准
    • Wonder Berry制酸劑在 Target 推出獨家口味
    • Mark Sands Pharma 法莫替丁錠獲得美國FDA核准
    • ENO 推出兩種新口味擴大產品組合：Jaljeera 和 Nimbu Masala

第14章競爭組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-4358BACA7E3E

[186 Pages Report] The Antacids Market size was estimated at USD 6.85 billion in 2023 and expected to reach USD 7.24 billion in 2024, at a CAGR 5.81% to reach USD 10.18 billion by 2030.

Antacid is a type of medication that is used to neutralize stomach acidity and alleviate symptoms associated with excess gastric acid. These include conditions such as heartburn, indigestion, and stomach upset, providing relief by increasing the pH balance in the stomach. The antacid products are available in various forms, including tablets, liquids, and powders to relieve symptoms associated with gastroesophageal reflux disease (GERD), heartburn, and peptic ulcers. The rising prevalence of GERD, heartburn, and other gastric ailments globally is driving the need for antacid products. Modern dietary habits and lifestyles contribute to increased incidences of acidity and related disorders, further propelling the demand for antacids. Continuous research and development aimed at enhancing product efficacy and reducing side effects positively impact market growth. However, stringent regulations regarding the approval and marketing of antacid products can delay product launches, hampering market growth. The availability of alternative therapies and treatments for acid-related disorders poses a significant challenge for market growth. Moreover, ongoing research into natural and organic ingredients can effectively relieve acidity and related conditions, creating opportunities for market growth. Ongoing innovation in drug delivery technologies to improve the efficacy and duration of action of antacid products, generating growth potential in the market.

KEY MARKET STATISTICS
Base Year [2023] USD 6.85 billion
Estimated Year [2024] USD 7.24 billion
Forecast Year [2030] USD 10.18 billion
CAGR (%) 5.81%

Regional Insights

In the Americas region, the antacids market is driven by a high prevalence of gastroesophageal reflux disease (GERD) and stress-induced gastritis, amongst other digestive disorders. Consumer preferences lean toward fast-acting, flavored, and chewable forms in major countries such as the United States and Canada. The EMEA region presents a diverse landscape for antacids as the EU countries prioritize medically proven, prescription-based treatments due to stringent regulations. The EMEA market is characterized by a strong presence of global pharmaceutical brands and a growing interest in antacids that offer additional health benefits, such as probiotics. The antacids market in the Middle East and Africa is expanding, driven by lifestyle diseases and an increasing preference for self-medication. Moreover, in the APAC region, the burgeoning middle-class population and increased healthcare spending in China and India are expanding the adoption of antacids in the region. The rising aging population in Japan and a strong focus on preventive healthcare bolster the use of antacids in the APAC region. The domestic antacids market in India is propelled by lifestyle changes, increased fast food consumption, and rising awareness of over-the-counter (OTC) remedies.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Antacids Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Growing population suffering from gastroesophageal reflux disease
      • Government initiatives and investments for domestic drug manufacturing worldwide
    • Market Restraints
      • Availability of home remedies and other alternatives for acidity-related issues
    • Market Opportunities
      • Development of more instantly effective and long-lasting antacids
      • Easy availability of antacids in the online pharmacy and regulation flexibility for OTC drugs
    • Market Challenges
      • Drug recall and contamination issues associated with the antacids
  • Market Segmentation Analysis
    • Drug Class: Increasing preference for acid neutralizers for improved therapeutic action
    • Indication: Expanding need for antacids for the management of gastroesophageal reflux disease for reducing the acid's ability to damage the esophageal lining.
    • Formulation: Rising preference for liquid antacid due to their already dissolved state, facilitating quicker relief from symptoms
    • Distribution Channel: Growing availability of antacids across retail pharmacies that provide instant access to antacids without the need for a prescription
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Antacids Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Antacids Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

TUMS Teams Up with DraftKings and Desus Nice to Launch TUMS Prop Bites, Allowing Big Game Fans to Go All In on Food for the First Time

TUMS partners with DraftKings to introduce an innovative platform, TUMS Prop Bites. This unique initiative creates awareness about making free food predictions by offering a chance to compare their selections with others nationwide. The brand's antacid tablets and chews are crafted to immediately relieve heartburn. These chewable solutions address symptoms such as heartburn, acid indigestion, sour stomach, and discomfort. [Published On: 2024-01-17]

Dexcel Pharma Acquires 8 OTC Brands to Strengthen its Consumer Healthcare Portfolio

Dexcel Pharma Ltd. announced its strategic acquisition of eight reputable over-the-counter (OTC) brands to diversify and strengthen its consumer healthcare offerings. The enhanced portfolio features well-known products such as EarCalm Spray, Sominex for sleep assistance, Wind-Eze as an antacid, Bisodol for indigestion relief, Cymex for cold sore treatment, Liberize for erectile dysfunction, Yeast Vite supplements, and MacKenzies Smelling Salts for catarrh and colds. [Published On: 2024-01-11]

Camber Pharmaceuticals Launches Generic Wellbutrin SR

Camber Pharmaceuticals expanded its product line by introducing Famotidine Powder for oral suspension, USP, a treatment developed to address various gastrointestinal conditions. Suitable for adults, this formulation effectively treats active duodenal and gastric ulcers, relieving the symptoms of non-erosive gastroesophageal reflux disease (GERD). [Published On: 2023-11-27]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Antacids Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Antacids Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aero Healthcare AU Pty Ltd, Alcon Industries, Alkem Laboratories Ltd., Allegiant Health, AstraZeneca plc, Bayer AG, Biocon Limited, Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Limited, Camber Pharmaceuticals, Inc., Cipla Limited, Daiichi Sankyo Company Limited, Dexcel Ltd., Dr. Reddy's Laboratories Ltd., GlaxoSmithKline PLC, Haleon PLC, Imerys S.A., J. B. Chemicals & Pharmaceuticals Limited, Johnson & Johnson Services, Inc., Magmit Pharmaceutical Co., Ltd., Mankind Pharma Ltd., Marksans Pharma, Nestle S.A., Novartis AG, Perrigo Company plc, Pfizer Inc., Raritan Pharmaceuticals, Inc., Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Swiss Chem Healthcare by Swastik Lifesciences, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., The Procter & Gamble Company, Upsher-Smith Laboratories, LLC by Bora Pharmaceuticals, Wonderbelly, and Zoic Pharmaceuticals Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Antacids Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Drug Class
    • Acid Neutralizers
      • Aluminum Hydroxide
      • Calcium Carbonate
      • Magnesium Hydroxide
      • Sodium Bicarbonate
    • H2 Antagonist
    • Promotility Agents
    • Proton Pump Inhibitor
  • Formulation
    • Liquid
    • Powder
    • Tablet
  • Indication
    • Gastroesophageal Reflux Disease
    • Indigestion/Dyspepsia
    • Peptic Ulcer Disease
  • Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing population suffering from gastroesophageal reflux disease
      • 5.1.1.2. Government initiatives and investments for domestic drug manufacturing worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of home remedies and other alternatives for acidity-related issues
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of more instantly effective and long-lasting antacids
      • 5.1.3.2. Easy availability of antacids in the online pharmacy and regulation flexibility for OTC drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Drug recall and contamination issues associated with the antacids
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Drug Class: Increasing preference for acid neutralizers for improved therapeutic action
    • 5.2.2. Indication: Expanding need for antacids for the management of gastroesophageal reflux disease for reducing the acid's ability to damage the esophageal lining.
    • 5.2.3. Formulation: Rising preference for liquid antacid due to their already dissolved state, facilitating quicker relief from symptoms
    • 5.2.4. Distribution Channel: Growing availability of antacids across retail pharmacies that provide instant access to antacids without the need for a prescription
  • 5.3. Market Trend Analysis
    • 5.3.1. Rising prevalence of gastroesophageal reflux disease across the Americas creating need for antacids
    • 5.3.2. Government campaigns creating awareness for enhancing digestive health in the Asia-Pacific
    • 5.3.3. Presence of well-established pharmaceutical industry and government support for domestic drug manufacturing in the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Antacids Market, by Drug Class

  • 6.1. Introduction
  • 6.2. Acid Neutralizers
  • 6.3. H2 Antagonist
  • 6.4. Promotility Agents
  • 6.5. Proton Pump Inhibitor

7. Antacids Market, by Formulation

  • 7.1. Introduction
  • 7.2. Liquid
  • 7.3. Powder
  • 7.4. Tablet

8. Antacids Market, by Indication

  • 8.1. Introduction
  • 8.2. Gastroesophageal Reflux Disease
  • 8.3. Indigestion/Dyspepsia
  • 8.4. Peptic Ulcer Disease

9. Antacids Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospital Pharmacy
  • 9.3. Online Pharmacy
  • 9.4. Retail Pharmacy

10. Americas Antacids Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Antacids Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Antacids Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. TUMS Teams Up with DraftKings and Desus Nice to Launch TUMS Prop Bites, Allowing Big Game Fans to Go All In on Food for the First Time
    • 13.3.2. Dexcel Pharma Acquires 8 OTC Brands to Strengthen its Consumer Healthcare Portfolio
    • 13.3.3. Camber Pharmaceuticals Launches Generic Wellbutrin SR
    • 13.3.4. Reckitt Launches Gaviscon Double Action in Tamil Nadu, Helping People with Acidity and Heartburn
    • 13.3.5. Wonderbelly Expands To Over 1,800 Target Stores to be Easily Accessible to a Broader Audience
    • 13.3.6. Upsher-Smith Launches Famotidine For Oral Suspension
    • 13.3.7. Zydus Secures Final Approval from the USFDA for its Esomeprazole Magnesium Product
    • 13.3.8. Wonderbelly Antacid Brings Exclusive Flavor to Target With Launch
    • 13.3.9. Marksans Pharma Gets USFDA Nod for Famotidine Tablets
    • 13.3.10. ENO Expands its Portfolio with Two New Flavors, Jaljeera and Nimbu Masala

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. ANTACIDS MARKET RESEARCH PROCESS
  • FIGURE 2. ANTACIDS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANTACIDS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANTACIDS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL ANTACIDS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANTACIDS MARKET DYNAMICS
  • FIGURE 7. GLOBAL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ANTACIDS MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL ANTACIDS MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL ANTACIDS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL ANTACIDS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS ANTACIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS ANTACIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES ANTACIDS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES ANTACIDS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ANTACIDS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. ANTACIDS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANTACIDS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANTACIDS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL ANTACIDS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANTACIDS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL ANTACIDS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANTACIDS MARKET SIZE, BY ALUMINUM HYDROXIDE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL ANTACIDS MARKET SIZE, BY ALUMINUM HYDROXIDE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANTACIDS MARKET SIZE, BY CALCIUM CARBONATE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL ANTACIDS MARKET SIZE, BY CALCIUM CARBONATE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANTACIDS MARKET SIZE, BY MAGNESIUM HYDROXIDE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL ANTACIDS MARKET SIZE, BY MAGNESIUM HYDROXIDE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANTACIDS MARKET SIZE, BY SODIUM BICARBONATE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL ANTACIDS MARKET SIZE, BY SODIUM BICARBONATE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANTACIDS MARKET SIZE, BY H2 ANTAGONIST, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL ANTACIDS MARKET SIZE, BY H2 ANTAGONIST, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANTACIDS MARKET SIZE, BY PROMOTILITY AGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL ANTACIDS MARKET SIZE, BY PROMOTILITY AGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL ANTACIDS MARKET SIZE, BY PROTON PUMP INHIBITOR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL ANTACIDS MARKET SIZE, BY PROTON PUMP INHIBITOR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL ANTACIDS MARKET SIZE, BY LIQUID, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL ANTACIDS MARKET SIZE, BY LIQUID, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL ANTACIDS MARKET SIZE, BY POWDER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL ANTACIDS MARKET SIZE, BY POWDER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL ANTACIDS MARKET SIZE, BY TABLET, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL ANTACIDS MARKET SIZE, BY TABLET, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL ANTACIDS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL ANTACIDS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL ANTACIDS MARKET SIZE, BY INDIGESTION/DYSPEPSIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL ANTACIDS MARKET SIZE, BY INDIGESTION/DYSPEPSIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL ANTACIDS MARKET SIZE, BY PEPTIC ULCER DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL ANTACIDS MARKET SIZE, BY PEPTIC ULCER DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL ANTACIDS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL ANTACIDS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL ANTACIDS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL ANTACIDS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL ANTACIDS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL ANTACIDS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS ANTACIDS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES ANTACIDS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES ANTACIDS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 134. AUSTRALIA ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 136. AUSTRALIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 143. CHINA ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 144. CHINA ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 145. CHINA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 146. CHINA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 153. INDIA ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 154. INDIA ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 155. INDIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 156. INDIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 163. INDONESIA ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 164. INDONESIA ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 165. INDONESIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 166. INDONESIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 173. JAPAN ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 174. JAPAN ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 175. JAPAN ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 176. JAPAN ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 183. MALAYSIA ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 184. MALAYSIA ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 185. MALAYSIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 186. MALAYSIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 194. PHILIPPINES ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 196. PHILIPPINES ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 203. SINGAPORE ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 204. SINGAPORE ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 205. SINGAPORE ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 206. SINGAPORE ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 214. SOUTH KOREA ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 216. SOUTH KOREA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 223. TAIWAN ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 224. TAIWAN ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 225. TAIWAN ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 226. TAIWAN ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 233. THAILAND ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 234. THAILAND ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 235. THAILAND ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 236. THAILAND ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 243. VIETNAM ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 244. VIETNAM ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 245. VIETNAM ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 246. VIETNAM ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 265. DENMARK ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 266. DENMARK ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 267. DENMARK ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 268. DENMARK ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 275. EGYPT ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 276. EGYPT ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 277. EGYPT ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 278. EGYPT ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 284. FINLAND ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 285. FINLAND ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 286. FINLAND ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 287. FINLAND ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 288. FINLAND ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 293. FRANCE ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 294. FRANCE ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 295. FRANCE ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 296. FRANCE ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 297. FRANCE ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 298. FRANCE ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 302. GERMANY ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 303. GERMANY ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 304. GERMANY ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 305. GERMANY ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 306. GERMANY ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 307. GERMANY ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 308. GERMANY ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 309. ISRAEL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 310. ISRAEL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 311. ISRAEL ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 312. ISRAEL ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 313. ISRAEL ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 314. ISRAEL ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 315. ISRAEL ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 316. ISRAEL ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 317. ISRAEL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 318. ISRAEL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 319. ITALY ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 320. ITALY ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 321. ITALY ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 322. ITALY ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 323. ITALY ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 324. ITALY ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 325. ITALY ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 326. ITALY ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 327. ITALY ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 328. ITALY ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 330. NETHERLANDS ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 331. NETHERLANDS ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 332. NETHERLANDS ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 333. NETHERLANDS ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 334. NETHERLANDS ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 335. NETHERLANDS ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 336. NETHERLANDS ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 337. NETHERLANDS ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 338. NETHERLANDS ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 339. NIGERIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 340. NIGERIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 341. NIGERIA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 342. NIGERIA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 343. NIGERIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 344. NIGERIA ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 345. NIGERIA ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 346. NIGERIA ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 347. NIGERIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 348. NIGERIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 349. NORWAY ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 350. NORWAY ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 351. NORWAY ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 352. NORWAY ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 353. NORWAY ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 354. NORWAY ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 355. NORWAY ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 356. NORWAY ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 357. NORWAY ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 358. NORWAY ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 359. POLAND ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 360. POLAND ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 361. POLAND ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 362. POLAND ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 363. POLAND ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 364. POLAND ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 365. POLAND ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 366. POLAND ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 367. POLAND ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 368. POLAND ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 369. QATAR ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 370. QATAR ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 371. QATAR ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 372. QATAR ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 373. QATAR ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 374. QATAR ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 375. QATAR ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 376. QATAR ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 377. QATAR ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 378. QATAR ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 379. RUSSIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 380. RUSSIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 381. RUSSIA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
  • TABLE 382. RUSSIA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
  • TABLE 383. RUSSIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 384. RUSSIA ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 385. RUSSIA ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 386. RUSSIA ANTACIDS MARKET SI